References
American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas (TX): American Heart Association, 2001
Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354–60
Kannel WB. Prevalence and implications of uncontrolled systolic hypertension. Drugs Aging 2003; 20(4): 277–86
Benetos A, Thomas F, Bean K, et al. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 2002; 162: 577–81
Hyman D, Pavlik V. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479–86
Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37: 869–74
Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957–63
Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 2000; 160: 2281–6
Deedwania PC. The changing face of hypertension: is systolic blood pressure the final answer? Arch Intern Med 2002; 162: 506–8
Kannel WB, Schwartz MJ, Mcnamara PM. Blood pressure and risk of coronary heart disease. The Framingham Study. Dis Chest 1969; 56: 43–52
Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (JNC V). Arch Intern Med 1993; 153: 154–83
Izzo J, Levy D, Black HR. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension 2000; 35: 1021–4
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265(4): 3255–64
Staessen JA, Fagard R, Thijs L, et al. Morbidity and mortality in the placebo controlled European trial on isolated systolic hypertension (Syst-Eur) in the elderly. Lancet 1997; 350: 757–64
Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446
Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002; 4: 393–404
Somes G, Pahor M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999; 159: 2004–9
Acknowledgements
No sources of funding were used to assist in the preparation of this commentary. The author has no conflicts of interest that are directly relevant to the content of this commentary.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basile, J.N. Systolic Blood Pressure Elevation. Drugs Aging 20, 287–288 (2003). https://doi.org/10.2165/00002512-200320040-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200320040-00007